These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

893 related items for PubMed ID: 27161894

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial.
    Carvalho JTG, Schneider M, Cuppari L, Grabulosa CC, T Aoike D, Q Redublo BM, C Batista M, Cendoroglo M, Maria Moyses R, Dalboni MA.
    PLoS One; 2017; 12(6):e0179540. PubMed ID: 28665937
    [Abstract] [Full Text] [Related]

  • 3. Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: Vitamin D3 megadose reduces inflammatory markers.
    de Medeiros Cavalcante IG, Silva AS, Costa MJ, Persuhn DC, Issa CT, de Luna Freire TL, da Conceição Rodrigues Gonçalves M.
    Exp Gerontol; 2015 Jun; 66():10-6. PubMed ID: 25827670
    [Abstract] [Full Text] [Related]

  • 4. Effect of vitamin D supplementation on selected inflammatory biomarkers in older adults: a secondary analysis of data from a randomised, placebo-controlled trial.
    Waterhouse M, Tran B, Ebeling PR, English DR, Lucas RM, Venn AJ, Webb PM, Whiteman DC, Neale RE.
    Br J Nutr; 2015 Sep 14; 114(5):693-9. PubMed ID: 26206095
    [Abstract] [Full Text] [Related]

  • 5. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.
    Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, Figueiredo JC, Ahnen DJ, Bresalier RS, Burke CA, Baron JA.
    J Clin Endocrinol Metab; 2014 Oct 14; 99(10):E2133-7. PubMed ID: 25070320
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.
    Bucharles S, Barberato SH, Stinghen AEM, Gruber B, Piekala L, Dambiski AC, Custodio MR, Pecoits-Filho R.
    J Ren Nutr; 2012 Mar 14; 22(2):284-291. PubMed ID: 21908203
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cholecalciferol Supplementation Did Not Change Interleukin-7 and B cell-Activating Factor Levels and CD95 Expression in B lymphocytes in Patients on Dialysis: A Randomized Pilot-Controlled Trial.
    de Carvalho JTG, Schneider M, Cuppari L, Grabulosa CC, Cendoroglo M, Dalboni MA.
    J Ren Nutr; 2019 Sep 14; 29(5):454-461. PubMed ID: 30686751
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D Status in Chronic Kidney Disease - UVB Irradiation Is Superior to Oral Supplementation.
    Krause R, Roth HJ, Kaase H, Stange R, Holick MF.
    Anticancer Res; 2016 Mar 14; 36(3):1397-401. PubMed ID: 26977042
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals.
    Pinzone MR, Di Rosa M, Celesia BM, Condorelli F, Malaguarnera M, Madeddu G, Martellotta F, Castronuovo D, Gussio M, Coco C, Palermo F, Cosentino S, Cacopardo B, Nunnari G.
    Eur Rev Med Pharmacol Sci; 2013 Jul 14; 17(14):1938-50. PubMed ID: 23877860
    [Abstract] [Full Text] [Related]

  • 13. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients.
    Ahearn TU, McCullough ML, Flanders WD, Long Q, Sidelnikov E, Fedirko V, Daniel CR, Rutherford RE, Shaukat A, Bostick RM.
    Cancer Res; 2011 Jan 15; 71(2):413-23. PubMed ID: 21084270
    [Abstract] [Full Text] [Related]

  • 14. High-dose vitamin D3 reduces circulating hepcidin concentrations: A pilot, randomized, double-blind, placebo-controlled trial in healthy adults.
    Smith EM, Alvarez JA, Kearns MD, Hao L, Sloan JH, Konrad RJ, Ziegler TR, Zughaier SM, Tangpricha V.
    Clin Nutr; 2017 Aug 15; 36(4):980-985. PubMed ID: 27402475
    [Abstract] [Full Text] [Related]

  • 15. Effect of Vitamin D Supplementation on Inflammatory Markers in Non-Obese Lebanese Patients with Type 2 Diabetes: A Randomized Controlled Trial.
    El Hajj C, Walrand S, Helou M, Yammine K.
    Nutrients; 2020 Jul 09; 12(7):. PubMed ID: 32659891
    [Abstract] [Full Text] [Related]

  • 16. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
    Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W, Someren JT, Tangpricha V.
    Endocr Pract; 2008 Jul 09; 14(1):10-7. PubMed ID: 18238736
    [Abstract] [Full Text] [Related]

  • 17. High-dose vitamin D in Addison's disease regulates T-cells and monocytes: A pilot trial.
    Penna-Martinez M, Filmann N, Bogdanou D, Shoghi F, Huenecke S, Schubert R, Herrmann E, Koehl U, Husebye ES, Badenhoop K.
    Nutrition; 2018 May 09; 49():66-73. PubMed ID: 29522979
    [Abstract] [Full Text] [Related]

  • 18. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.
    Ramirez-Sandoval JC, Arvizu-Hernandez M, Cruz C, Vazquez-Cantu B, Rojas-Concha LJ, Tamez L, Reynerio F, Gomez FE, Correa-Rotter R.
    J Nephrol; 2019 Aug 09; 32(4):645-659. PubMed ID: 30888584
    [Abstract] [Full Text] [Related]

  • 19. VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.
    Courbebaisse M, Alberti C, Colas S, Prié D, Souberbielle JC, Treluyer JM, Thervet E.
    Trials; 2014 Nov 06; 15():430. PubMed ID: 25376735
    [Abstract] [Full Text] [Related]

  • 20. Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease.
    Alvarez JA, Zughaier SM, Law J, Hao L, Wasse H, Ziegler TR, Tangpricha V.
    Eur J Clin Nutr; 2013 Mar 06; 67(3):264-9. PubMed ID: 23361158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.